SolidAIRity® Flex (Adult)
Endotracheal tube securement to prevent unplanned extubation
Pre-commercialActive
Key Facts
Indication
Endotracheal tube securement to prevent unplanned extubation
Phase
Pre-commercial
Status
Active
Company
About Securisyn Medical
Securisyn Medical is a pre-revenue, late-stage development company preparing for the U.S. commercial launch of its flagship product, the SolidAIRity® Flex for adults, in late 2024, with a pediatric version expected in 2026. The company targets a critical and costly complication in intensive care—unplanned extubation—with a differentiated securement technology. Led by a seasoned team with clinical, operational, and commercial expertise, Securisyn is positioned to address a significant unmet need in hospital airway safety, though its success hinges on successful market entry and adoption against established competitors.
View full company profile